← Back to Screener
Voyager Acquisition Corp Class A Ordinary Shares (VACH)
Price$12.88
Favorite Metrics
Price vs S&P 500 (26W)14.39%
Price vs S&P 500 (4W)13.17%
Market Capitalization$407.33M
P/E Ratio (Annual)45.31x
All Metrics
Book Value / Share (Quarterly)$8.12
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.02
Price vs S&P 500 (YTD)17.45%
EPS (TTM)$0.28
10-Day Avg Trading Volume0.01M
EPS Excl Extra (TTM)$0.28
EPS (Annual)$0.28
ROI (Annual)3.50%
Cash / Share (Quarterly)$0.01
P/E Basic Excl Extra (TTM)45.31x
P/E Normalized (Annual)45.31x
ROA (Last FY)3.33%
EBITD / Share (TTM)$-0.06
Cash Flow / Share (Annual)$-0.02
P/B Ratio1.59x
P/B Ratio (Quarterly)1.31x
ROA (TTM)3.38%
EPS Growth QoQ (YoY)5.27%
EPS Incl Extra (Annual)$0.28
Current Ratio (Annual)0.15x
Quick Ratio (Quarterly)0.14x
3-Month Avg Trading Volume0.12M
P/E Incl Extra (TTM)45.31x
52-Week High$15.68
EPS Excl Extra (Annual)$0.28
26-Week Price Return23.14%
Quick Ratio (Annual)0.14x
13-Week Price Return21.05%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)0.15x
Enterprise Value$407.148
Cash / Share (Annual)$0.01
3-Month Return Std Dev60.89%
ROE (Last FY)3.50%
EPS Basic Excl Extra (Annual)$0.28
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$0.28
ROI (TTM)3.54%
Revenue / Share (Annual)$0.00
P/E Ratio (TTM)45.31x
EPS Growth TTM (YoY)147.99%
Year-to-Date Return20.71%
5-Day Price Return5.14%
EPS Normalized (Annual)$0.28
Month-to-Date Return7.24%
EBITD / Share (Annual)$-0.06
P/E Excl Extra (TTM)45.31x
EPS Basic Excl Extra (TTM)$0.28
P/B Ratio (Annual)1.31x
Book Value / Share (Annual)$8.12
Price vs S&P 500 (13W)18.19%
Beta-0.39x
Revenue / Share (TTM)$0.00
ROE (TTM)3.54%
52-Week Low$9.24
Industry Peers — Biological Products(89)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
VACHVoyager Acquisition Corp Class A Ordinary Shares | — | — | — | — | $12.88 |
AMGNAmgen Inc | 5.21x | 9.95% | 73.30% | 2.93% | $355.30 |
GILDGilead Sciences Inc | 5.80x | 2.40% | 78.83% | 133.64% | $137.64 |
ARGXargenx SE American Depositary Shares | 12.46x | 89.56% | 150.91% | — | $849.04 |
BNTXBioNTech SE American Depositary Share | 8.99x | -11.81% | 84.21% | — | $102.92 |
BIIBBiogen Inc. Common Stock | 2.63x | 2.22% | 75.69% | -18.77% | $177.35 |
MRNAModerna, Inc. Common Stock | 10.91x | -39.93% | 70.32% | — | $53.72 |
NBIXNeurocrine Biosciences Inc | 4.68x | 21.45% | 98.18% | 2.31% | $133.25 |
EXELExelixis Inc | 5.02x | 6.85% | 96.39% | 31.10% | $44.89 |
TECHBio-Techne Corp. | 7.62x | 1.64% | 66.60% | -20.58% | $59.23 |
HALOHalozyme Therapeutics, Inc. | 5.88x | 37.55% | 83.62% | 22.89% | $69.29 |
About
Voyager Acquisition Corp is a special purpose acquisition company (SPAC) formed to identify, acquire, and operate a business in a target industry. The company seeks to combine with an operating company to create value for shareholders through strategic acquisition and operational improvements.